[Critical Analysis of the Saralasintest in the Diagnosis of Hypertension (author's Transl)]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1977 Jul 1

PMID 895003

Authors

A Rockel

H Wernze

B Sabel

A Heidland

Affiliations

Soon will be listed here.

Abstract

The reliability of the angiotensin II (AT II)-antagonist Saralasin in the diagnosis of AT II-dependent forms of hypertension was investigated in 61 cases of hypertension of different etiology. In 14 patients, lowering of blood pressure by Saralasin suggested an AT II-dependent hypertension which could be ascertained in 8 patients (5 had undergone successful surgery) by increased levels of plasma-renin-activity (PRA), AT II, PRA-ratio in renal vein blood and by angiography. Besides, depressor reactions by Saralasin yielded additional information in three patients with renovascular hypertension but normal levels of PRA and AT II, in two patients with high renin essential hypertension and one patient with pheochromocytoma. This test seems to be valuable in the diagnosis of renin-dependent hypertension.

References

Brunner H, Gavras H, LARAGH J . Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet. 1973; 2(7837):1045-8. DOI: 10.1016/s0140-6736(73)92657-3. View

Blair-West J, Coghlan J, Denton D, Funder J, SCOGGINS B, Wright R . Inhibition of renin secretion by systemic and intrarenal angiotensin infusion. Am J Physiol. 1971; 220(5):1309-15. DOI: 10.1152/ajplegacy.1971.220.5.1309. View

Marks L, Maxwell M, Kaufman J . Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension. Lancet. 1975; 2(7939):784-7. View

Streeten D, Freiberg J, Anderson G, Dalakos T . Identification of angiotensinogenic hypertension in man using 1-sar-8-ala-angiotensin II (Saralasin, P-113). Circ Res. 1975; 36(6 Suppl 1):125-32. DOI: 10.1161/01.res.36.6.125. View

FELDBERG W, Lewis G . THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN. J Physiol. 1964; 171:98-108. PMC: 1368779. DOI: 10.1113/jphysiol.1964.sp007364. View

Maebashi M, Miura Y, Yoshinaga K, Sato K . Plasma renin activity in pheochromocytoma. Jpn Circ J. 1968; 32(10):1427-32. DOI: 10.1253/jcj.32.1427. View

Burns A, Tesluk H, Palmer J . Hypertension associated with vascular lesion of neurofibromatosis. J Urol. 1972; 108(5):676-9. DOI: 10.1016/s0022-5347(17)60837-1. View

Rockel A, Wernze H, Spech H, Scheitza E, Hennemann H, Heidland A . [Diagnostic relevancy of saralasin in renin-dependent hypertension]. Verh Dtsch Ges Inn Med. 1976; 82 Pt 2:1307-10. View

Wernze H, Rosenthal J . [The renin-angiotensin system: metodical and clinical problems. Report of a workshop held November 23/24 in Würzburg]. Med Welt. 1976; 27(5):212-9. View

10.

PETTINGER W, Keeton K, Tanaka K . Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients. Clin Pharmacol Ther. 1975; 17(2):146-58. DOI: 10.1002/cpt1975172146. View

11.

Schroeder E, Anderson G, Goldman S, Streeten D . Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney Int. 1976; 9(6):511-9. DOI: 10.1038/ki.1976.65. View

12.

Rockel A, Heidland A, Appel E, Palm D . Depressor effect of saralasin in hypertensive crisis due to pheochromocytoma. N Engl J Med. 1977; 296(1):50-1. DOI: 10.1056/NEJM197701062960117. View

13.

Case D, Wallace J, Keim H, SEALEY J, LARAGH J . Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med. 1976; 60(6):825-36. DOI: 10.1016/0002-9343(76)90903-7. View

14.

Schurch W, Messerli F, Genest J, Lefebvre R, Roy P, Carter P . Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aorta. Can Med Assoc J. 1975; 113(9):879-85. PMC: 1956686. View

15.

Shade R, Davis J, Johnson J, Gotshall R, Spielman W . Mechanism of action of antiotensin II and antidiuretic hormone on renin secretion. Am J Physiol. 1973; 224(4):926-9. DOI: 10.1152/ajplegacy.1973.224.4.926. View

16.

KERZNER M, Reeves J, DeNyse D, CLAUNCH B . Pheochromocytoma with renal artery compression in an identical twin. Arch Intern Med. 1968; 121(1):91-4. View

17.

CORNELL S, KIRKENDALL W . Neurofibromatosis of the renal artery. An unusual cause of hypertension. Radiology. 1967; 88(1):24-8. DOI: 10.1148/88.1.24. View

18.

Nussberger J, Beckerhoff R, Vetter W, Armbruster H, Siegenthaler W . A simple and sensitive radioimmunoassay for plasma angiotensin II. Acta Endocrinol Suppl (Copenh). 1973; 173:157. DOI: 10.1530/acta.0.072s157. View

19.

PALS D, MASUCCI F, DENNING Jr G, Sipos F, Fessler D . Role of the pressor action of angiotensin II in experimental hypertension. Circ Res. 1971; 29(6):673-81. DOI: 10.1161/01.res.29.6.673. View

20.

PETTINGER W, MITCHELL H . Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. N Engl J Med. 1975; 292(23):1214-7. DOI: 10.1056/NEJM197506052922304. View